Healthcare Industry News: ultrasound
News Release - March 11, 2016
MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee(R), MedCom's Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy & Therapy Guidance, for use in Conjunction With Hitachi Ultrasound SystemsThe combined Hitachi Noblus and MedCom BiopSee® systems will be showcased at the European Association of Urology (EAU) annual meeting in Munich, March 12th-14th, 2016, Booth #E16
ZUG, Switzerland, March 11, 2016 -- (Healthcare Sales & Marketing Network) -- MedCom GmbH, Darmstadt, Germany and Hitachi Medical Systems Europe, Zug, Switzerland, announce an agreement to distribute through Hitachi's subsidiaries sales network in Europe BiopSee®, MedCom's fusion imaging system for stereotactic, navigated, targeted prostate biopsy & therapy guidance, for use in conjunction with Hitachi ultrasound systems. Hitachi will be the sole distributor of the BiopSee® products in this territory for Hitachi's installed base and when bundled with Hitachi's products.
BiopSee® fusion imaging station combines multi-parametric MRI with real-time ultrasound. It offers thereby exceptional precision in stereotactic and navigated interventions with intuitive workflow that can bring state-of-the-art technology to everyday urology practice. The BiopSee® software supports 3D ultrasound image acquisition, rigid/elastic fusion with MRI, planning, navigation, reporting of interventional procedures, and interfaces to focal therapy devices. An electronically tracked stepper provides millimetric precision for a transperineal approach, while a magnetically tracked freehand probe can be used for navigated TRUS and abdominal procedures.
The combined forces of the MedCom BiopSee® system, powered by urology's Gold Standard ultrasound from Hitachi, offer "the best of both worlds" to medical practitioners and patients alike: the superior quality of Hitachi's ultrasound with its wide variety of available transducers together with BiopSee's® intuitive workflow, documentation and reporting, opening new possibilities for future patient management. 'I am excited at the potential of this partnership to bring new and innovative clinical solutions to our customers', said Mr. Chris Japp, President & CEO of Hitachi Medical Systems Europe.
The agreement allows Hitachi to respond rapidly to market needs providing flexible solutions for improved diagnostic and therapeutic image guidance in the field of prostate management.
Hitachi Medical Systems Europe are showcasing the combined Noblus and BiopSee® systems at the 2016 European Association of Urology annual meeting in Munich, March 12th-14th, 2016, Booth # E16. In addition you can see & test both systems at the ESU/ESUT/ESUI Hands-on training in MRI Fusion, ICM building, Hall B0, level 0, Sunday, March 13th, 10.00-12.00 (HOT 29) and 14.00-16.00 (HOT 30).
About Hitachi Medical Systems Europe
Hitachi Medical Corporation is a globally acting enterprise, belonging to the Japanese Hitachi Ltd., a leading international electronics group with more than 320,000 employees worldwide. Hitachi Medical Corporation in Europe is represented by Hitachi Medical Systems Europe Holding AG, Zug, Switzerland. The company is a first choice supplier of open and powerful high-field MRI systems, multi-slice CT systems as well as medical ultrasound, endoscopic and topography systems (NIRS). ultrasound expertise encompasses clinical applications such as radiology, internal medicine, obstetrics/gynaecology, cardiology, gastroenterology, urology and surgery. Hitachi Medical Systems Europe offers a complete range of solutions to address a wide range of medical challenges. For more information about Hitachi Medical Systems Europe Holding AG, please visit http://www.hitachi-medical-systems.eu.
About Hitachi, Ltd.
Hitachi, Ltd. (TSE:6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges with our talented team and proven experience in global markets. The company is focusing more than ever on the Social Innovation Business, which includes power & infrastructure systems, information & telecommunication systems, construction machinery, high functional materials & components, automotive systems, healthcare and others. For more information about Hitachi Ltd., please visit http://www.hitachi.com/.
MedCom was founded in 1997 and is specialized in the field of medical imaging. MedCom offers innovative and advanced imaging-based products with emphasis on interventional/surgical navigation and cancer treatment solutions (instrument navigation, brachytherapy, patient positioning & verification, virtual simulation). MedCom developed the first commercially released "fusion imaging" & navigation product for liver (2002) and prostate (2007). As an OEM/B2B company, MedCom is providing products for various global corporations offering integrated clinical solutions, as well as to high-end clinics in the research sector. For more information about MedCom GmbH, please visit http://www.medcom-online.de.
Source: Hitachi Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.